FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastat...
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer
About this item
Full title
Author / Creator
Anscher, Mitchell S. , Chang, Elaine , Gao, Xin , Gong, Yutao , Weinstock, Chana , Bloomquist, Erik , Adeniyi, Oluseyi , Charlab, Rosane , Zimmerman, Sarah , Serlemitsos‐Day, Maritsa , Ning, Yang Min , Mayrosh, Ruth , Fuller, Barbara , Trentacosti, Ann Marie , Gallagher, Pamela , Bijwaard, Karen , Philip, Reena , Ghosh, Soma , Fahnbulleh, Frances , Diggs, Felicia , Arora, Shaily , Goldberg, Kirsten B. , Tang, Shenghui , Amiri‐Kordestani, Laleh , Pazdur, Richard , Ibrahim, Amna and Beaver, Julia A.
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
The U.S. Food and Drug Administration (FDA) granted accelerated approval to rucaparib in May 2020 for the treatment of adult patients with deleterious BRCA mutation (germline and/or somatic)‐associated metastatic castrate‐resistant prostate cancer (mCRPC) who have been treated with androgen receptor‐directed therapy and a taxane. This approval was...
Alternative Titles
Full title
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer
Authors, Artists and Contributors
Author / Creator
Chang, Elaine
Gao, Xin
Gong, Yutao
Weinstock, Chana
Bloomquist, Erik
Adeniyi, Oluseyi
Charlab, Rosane
Zimmerman, Sarah
Serlemitsos‐Day, Maritsa
Ning, Yang Min
Mayrosh, Ruth
Fuller, Barbara
Trentacosti, Ann Marie
Gallagher, Pamela
Bijwaard, Karen
Philip, Reena
Ghosh, Soma
Fahnbulleh, Frances
Diggs, Felicia
Arora, Shaily
Goldberg, Kirsten B.
Tang, Shenghui
Amiri‐Kordestani, Laleh
Pazdur, Richard
Ibrahim, Amna
Beaver, Julia A.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7873319
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7873319
Other Identifiers
ISSN
1083-7159
E-ISSN
1549-490X
DOI
10.1002/onco.13585
